Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

FDG-PET imaging in patients with pulmonary carcinoid tumor.

Moore W, Freiberg E, Bishawi M, Halbreiner MS, Matthews R, Baram D, Bilfinger TV.

Clin Nucl Med. 2013 Jul;38(7):501-5. doi: 10.1097/RLU.0b013e318279f0f5.

PMID:
23486331
2.
3.

Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.

Krüger S, Buck AK, Blumstein NM, Pauls S, Schelzig H, Kropf C, Schumann C, Mottaghy FM, Hombach V, Reske SN.

J Intern Med. 2006 Dec;260(6):545-50.

4.

Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.

Lococo F, Perotti G, Cardillo G, De Waure C, Filice A, Graziano P, Rossi G, Sgarbi G, Stefanelli A, Giordano A, Granone P, Rindi G, Versari A, Rufini V.

Clin Nucl Med. 2015 Mar;40(3):e183-9. doi: 10.1097/RLU.0000000000000641.

PMID:
25608152
5.

Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.

Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.

Ann Nucl Med. 2008 Apr;22(3):165-70. doi: 10.1007/s12149-007-0112-1. Erratum in: Ann Nucl Med. 2010 Apr;24(3):231. Kim, Suk C [corrected to Kim, Suk Chul].

PMID:
18498030
6.

Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.

Stefani A, Franceschetto A, Nesci J, Aramini B, Proli C, Kaleci S, Casolo A, Massi L, Casali C, Morandi U.

J Cardiothorac Surg. 2013 Dec 4;8:223. doi: 10.1186/1749-8090-8-223.

7.

Bronchogenic carcinoid tumours that are 18F-fluorodeoxyglucose avid on positron emission tomography.

Hunt BM, Horton MP, Vallières E.

Eur J Cardiothorac Surg. 2014 Mar;45(3):527-30. doi: 10.1093/ejcts/ezt436.

PMID:
24047710
8.

Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.

Chen CJ, Lee BF, Yao WJ, Cheng L, Wu PS, Chu CL, Chiu NT.

AJR Am J Roentgenol. 2008 Aug;191(2):475-9. doi: 10.2214/AJR.07.3457.

PMID:
18647920
9.
10.

Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K.

J Nucl Med. 2006 Mar;47(3):426-31.

11.
12.

Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.

Gasparri R, Rezende GC, Fazio N, Maisonneuve P, Brambilla D, Travaini LL, Paganelli G, Petrella F, Galetta D, Spaggiari L.

Q J Nucl Med Mol Imaging. 2015 Dec;59(4):446-54.

PMID:
26416036
13.
14.

Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?

Alpay L, Lacin T, Kanbur S, Kiral H, Ersoz E, Bayram S, Dogruyol T, Baysungur V, Yalcinkaya I.

Hell J Nucl Med. 2013 Sep-Dec;16(3):213-7.

15.

Evaluation of primary pulmonary carcinoid tumors using FDG PET.

Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC.

AJR Am J Roentgenol. 1998 May;170(5):1369-73.

PMID:
9574618
16.

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.

J Clin Oncol. 2004 Aug 15;22(16):3255-60.

PMID:
15310769
17.

Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.

Venkitaraman B, Karunanithi S, Kumar A, Khilnani GC, Kumar R.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):856-64. doi: 10.1007/s00259-013-2659-5.

PMID:
24435773
18.

[Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].

Martins Rde C, Almeida SA, Siciliano AA, Landesmann MC, Silva FB, Franco CA, Fonseca LM.

J Bras Pneumol. 2008 Jul;34(7):473-80. Portuguese.

19.

Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.

Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH.

Lung Cancer. 2009 Aug;65(2):180-6. doi: 10.1016/j.lungcan.2008.11.015.

PMID:
19155090
20.

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

Kayani I, Conry BG, Groves AM, Win T, Dickson J, Caplin M, Bomanji JB.

J Nucl Med. 2009 Dec;50(12):1927-32. doi: 10.2967/jnumed.109.066639.

Items per page

Supplemental Content

Support Center